Transgender individuals may be at higher risk for myocardial infarction and death due to cardiovascular disease, according to several studies. This increased risk may be due to the hormone therapy that transgender patients take for masculinization or feminization. A review authored by Michael S. Irwig, MD, associate professor of medicine at the George Washington University (GW) School of Medicine…
A new software to calculate the pressure drop and vFFR value (vessel Fractional Flow Reserve) in the coronary artery non-invasively was presented to interventional cardiovascular experts at EuroPCR 2018 in Paris. The software called CAAS vFFR (Cardiovascular Angiographic Analysis Systems for vessel Fractional Flow Reserve) was developed by Pie Medical Imaging (Esaote Group). The vFFR calculation…
People who consume an egg a day could significantly reduce their risk of cardiovascular diseases compared with eating no eggs, suggests a study carried out in China, published in the journal Heart. Cardiovascular disease (CVD) is the leading cause of death and disability worldwide, including China, mostly due to ischaemic heart disease and stroke (including both haemorrhagic and ischaemic…
Google AI has made a breakthrough: successfully predicting cardiovascular problems such as heart attacks and strokes simply from images of the retina, with no blood draws or other tests necessary. This is a big step forward scientifically, Google AI officials said, because it is not imitating an existing diagnostic but rather using machine learning to uncover a surprising new way to predict these…
Standard medical tests miss nearly two-thirds of heart attack diagnoses, reveals research presented at CMR 2018. “Unrecognised MI has a poor short-term prognosis but until now the long-term outlook was unknown,” said lead author Dr Tushar Acharya, a cardiologist at the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, US. “This study investigated long-term…
Smoking just one cigarette a day carries a much higher risk of developing coronary heart disease and stroke than expected – about half the risk of smoking 20 per day –concludes a University College London (UCL)-led review of the evidence. The researchers say their findings, published in the BMJ, have important consequences for many smokers and health professionals who believe that smoking…
New research presented at APHA’s 2017 Annual Meeting and Expo examined the burden of air pollution and its association with mortality in Chinese cities. The study by researchers at Drexel University Dornsife School of Public Health showed a significant correlation between higher air quality index concentrations and higher mortality rates. The study is the first to provide strong evidence of the…
Acknowledging the need for faster ultrasound automation, Dr Alexander Weichert explained how automated procedures can assist in the early detection of cardiovascular disease and prenatal diagnostic testing, and why a detailed prenatal diagnosis can reduce mortality and morbidity.
Study shows a simplified examination can be performed routinely on low-risk populations during the first trimester of pregnancy.
A new study suggests that middle-aged people who report that they are slow walkers could be at higher risk of heart disease compared to the general population.
Researchers discover a new molecule, ‘Singheart’, that may hold the key to triggering the regeneration and repair of damaged heart cells.
A new study suggests that a single exposure to e-cigarette (e-cig) vapor may be enough to impair vascular function.
Cardiology in extreme environments takes centre stage at the British Cardiovascular Society (BCS) annual conference.
A vaccine to immunise people against high levels of cholesterol and the narrowing of the arteries caused by build-up of fatty material (atherosclerosis) may be possible following successful results in mice. Now, a phase I trial in patients has started to see if the findings translate to humans.
Robocath, a medical robotics start-up that designs and develops innovative solutions for the treatment of cardiovascular diseases, announces the conclusion of a new round of fundraising worth €4.7 million. This round was led by M Capital and Normandie Participations. It also involved past investors Go Capital and NCI, who have been supporting the company since 2013.
Researchers have found that people with A, B, and AB blood types may be at greater risk of cardiovascular events - particularly heart attack - than individuals with O blood types.
Royal Philips today announced that the results from two large clinical trials comparing patient outcomes using instant wave-free ratio (iFR) and fractional flow reserve (FFR) in the diagnosis and treatment of heart disease have been published in the New England Journal of Medicine. First released in 2013, iFR is an innovative pressure-derived index unique to Philips, a global leader in…
SCHILLER is very pleased to introduce the 2nd generation of its most successful ECG device: Building on the solidly proven AT-1 and enhanced with the latest technology, the AT-1 G2 distinguishes itself by its outstanding signal quality and the newest interpretation algorithm. Userfriendliness is guaranteed with step-by-step workflow and easy patient data entry. A colour screen and an…
EPIC Alliance experts at the European Society of Cardiology (ESC) congress presented original research and real-world clinical evidence on non-responders to cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) ablation.
Big Data has the potential to turn the approach to science and research on its head, according to leading expert Professor Viktor Mayer-Schönberger. In the future, he believes, researchers could adopt a position where they ‘start with the data and then come up with the question.’
As men appear to have higher risk of cardiovascular disease (CVD) than women of a similar age – with vascular calcification a strong predictor of mortality and morbidity from CVD – a team from the University of Edinburgh hopes that exploration of a link between gender and calcification could help unlock the pathway to new therapies. The researchers have been looking at whether sex hormones…
SCHILLER is looking forward to ESC Congress 2016. Come and visit us at booth E4-O200 and explore our latest innovations!
It’s well known that cardiovascular disease (CVD) is the leading cause of death in the UK and worldwide. In the UK it is responsible for more than 73,000 deaths annually, affecting 1 in 6 men and 1 in 10 women. With the emergence of such startling statistics, this begs the question, why do routine cholesterol tests still rely on the basic biomarkers high density lipoprotein (HDL), low density…
Topics of big data, the genetic basis of coronary artery disease and sudden cardiac death in the young are among key subjects for British cardiologists at their 2016 annual conference. With a central theme of “Prediction and Prevention”, the 2016 British Cardiovascular Society annual conference takes place in Manchester from June 6-8 and features innovative and interactive presentations,…
